Enrolments Completed for Phase 2 Acne Treatment Trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
Earlier from Avecho Biotechnology
- Receipt of $2.4m R&D Tax Incentive
- Phosphagenics Announces Results of TPM/Oxycodone Ph2a Trial
- R & D Taxation Incentive
- Positive Results for Weaner Pig Feed Efficiency Trial
- POH to Proceed with Twice Weekly Oxycodone Patch Development
Later from Avecho Biotechnology
- December 2012 Appendix 4E and Audited Financial Report
- Invoicing and Accounting Irregularities
- Invoicing and Accounting Misappropriations Investigation
- Oxycodone Patch Update
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology